The study shores up hopes of therapies that could repair damage in other organs
Sinclair and his team, however, warned that the findings need replication in further studies, including in different animal models, before any human experiments are conducted.
Despite this, the results open the gateway to designing treatments for a range of age-related human diseases.
If proven to be successful in further studies, the world could expect new therapies employing a similar approach in repairing damage in other organs and possibly treat age-related diseases in humans, according to the Harvard team.
“If affirmed through further studies, these findings could be transformative for the care of age-related vision diseases like glaucoma and to the fields of biology and medical therapeutics for the disease at large,” Sinclair said.
While it looks encouraging, it’s not ready for human testing yet, the study added.
“At the beginning of this project, many of our colleagues said our approach would fail or would be too dangerous to ever be used,” author Yuancheng Lu stated. “Our results suggest this method is safe and could potentially revolutionize the treatment of the eye and many other organs affected by aging.”
